All Aboard! Takeda’s Dengue Fever Vaccine Holds Up Over 4.5 Years
June 9, 2022Bluebird gene therapy overcomes safety worries to snag a win at FDA advisory panel
June 9, 2022Takeda announced results from its Phase III clinical trial on TAK-003, its dengue fever vaccine candidate, at the Northern European Conference of Travel Medicine.
